上海凯鑫(300899) - 2021 Q2 - 季度财报

Financial Performance - The company's operating revenue for the first half of 2021 was ¥107,925,923.15, representing a 12.84% increase compared to ¥95,647,466.58 in the same period last year[21]. - The net profit attributable to shareholders of the listed company decreased by 21.37% to ¥20,543,510.48 from ¥26,126,430.57 in the previous year[21]. - Basic earnings per share dropped by 41.03% to ¥0.3221 from ¥0.5462 in the previous year[21]. - The company's weighted average return on equity decreased to 3.28% from 11.09% in the previous year, a decline of 7.81%[21]. - The company achieved operating revenue of 108 million yuan, an increase of 12.84% compared to the same period last year[42]. - Net profit attributable to shareholders was 20.54 million yuan, a decrease of 21.37% year-on-year[42]. - The total comprehensive income for the first half of 2021 was CNY 20,438,524.65, compared to CNY 26,036,041.42 in the same period of 2020, showing a decrease of around 21.5%[153]. - The total profit for the first half of 2021 was CNY 23,309,470.19, compared to CNY 30,090,400.42 in the same period of 2020, representing a decrease of about 22.5%[155]. Cash Flow and Investments - The net cash flow from operating activities improved significantly, reaching ¥33,106,430.82, compared to a negative cash flow of ¥19,959,081.86 in the same period last year, marking a 265.87% increase[21]. - The company's cash and cash equivalents decreased by 1,172.21% to -¥195,862,017.46, largely due to investments in financial products[54]. - The total investment during the reporting period was ¥359,413,247.33, reflecting a staggering increase of 6,278.07% compared to the previous year[65]. - The company reported a total cash inflow from investment activities of ¥161,009,508.43, with a substantial cash outflow of ¥359,413,247.33, leading to a net cash outflow of ¥198,403,738.90[161]. - The company reported a credit impairment loss of CNY -1,255,173.11 in the first half of 2021, an improvement from CNY -1,567,250.34 in the same period of 2020[155]. Assets and Liabilities - Total assets increased by 5.81% to ¥729,835,216.72 from ¥689,775,637.15 at the end of the previous year[21]. - The total liabilities increased to CNY 104,073,603.94 in the first half of 2021 from CNY 64,292,667.22 in the same period last year, marking a significant rise of 62%[149]. - The company's total assets as of June 30, 2021, amounted to CNY 735,378,629.03, compared to CNY 689,642,994.13 at the end of 2020, representing a growth of 6.6%[148]. - The total equity attributable to shareholders increased to CNY 631,305,025.09 from CNY 625,350,326.91, a marginal increase of 0.3%[149]. Research and Development - Research and development investment rose significantly by 59.96% to ¥7,125,408.50 from ¥4,454,609.37, indicating a strong commitment to innovation[54]. - R&D personnel account for 31.11% of the total workforce, emphasizing the importance of talent cultivation in R&D efforts[43]. - The company specializes in membrane separation technology research and development, providing comprehensive solutions for industrial clients to optimize processes and reduce emissions[177]. - The company is focused on research and development of new technologies to improve its competitive edge in the market[176]. Market and Strategic Plans - The company plans not to distribute cash dividends or issue bonus shares[5]. - The report includes a detailed discussion of the company's future plans and strategies, although these do not constitute a commitment to investors[4]. - The company aims to improve operational efficiency through strategic mergers and acquisitions in the upcoming quarters[166]. - The company plans to enhance its market expansion strategies, focusing on new product development and technological advancements[166]. Operational Risks and Challenges - The company faces operational risks due to the COVID-19 pandemic, affecting project timelines and increasing uncertainty[85]. - The company is exposed to exchange rate fluctuation risks, particularly with USD and EUR, which may impact profitability and procurement costs[86]. - Accounts receivable risks may increase as the company expands its customer base, necessitating strict credit management[86]. Compliance and Governance - The company has adhered to legal requirements for information disclosure, ensuring timely and accurate communication with investors[99]. - The financial statements were approved by the board of directors on August 25, 2021, ensuring compliance with accounting standards[178]. - The company has assessed its ability to continue as a going concern for the next 12 months and found no significant doubts regarding its sustainability[182]. Environmental and Social Responsibility - The company has obtained ISO 14001 certification for its environmental management system, ensuring compliance with international standards[97]. - The company emphasizes its values of "professionalism, innovation, integrity, and win-win" to enhance employee skills and innovation capabilities[99]. - The company has organized employee vaccination efforts in response to national calls for COVID-19 prevention[99].